central nervous system multiparameter optimization (cns mpo) algorithm (Pfizer Inc)
90
Structured Review
Pfizer Inc
central nervous system multiparameter optimization (cns mpo) algorithm
Central Nervous System Multiparameter Optimization (Cns Mpo) Algorithm, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/central+nervous+system+multiparameter+optimization+(cns+mpo)+algorithm/cns+multiparameter+optimization++cns+mpo++algorithm/pm40198203-196-1-11
Average 90 stars, based on 1 article reviews
Central Nervous System Multiparameter Optimization (Cns Mpo) Algorithm, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/central+nervous+system+multiparameter+optimization+(cns+mpo)+algorithm/cns+multiparameter+optimization++cns+mpo++algorithm/pm40198203-196-1-11
Average 90 stars, based on 1 article reviews
central nervous system multiparameter optimization (cns mpo) algorithm - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Reporter Genes for Brain Imaging Using MRI, SPECT and PET Article Snippet: A central Article Title: Guided rational design with scaffold hopping leading to novel histamine H 3 receptor ligands. Article Snippet: During the past decades, histamine H3 receptors have received widespread attention in pharmaceutical research due to their involvement in pathophysiology of several diseases such as neurodegenerative disorders.. In this context, blocking of these receptors is of paramount importance in progression of such diseases.. In the current investigation, novel histamine H3 receptor ligands were designed by exploiting scaffold-hopping drug-design strategy. Article Title: Lead Optimization of Positive Allosteric K V 7.2/3 Channel Modulators toward Improved Balance of Lipophilicity and Aqueous Solubility. Article Snippet: The voltage-gated potassium channel KV7.2/3 is gaining attention for its association with several medical indications.. While recently reported, potent compounds aimed to fill the therapeutic gap left by market-withdrawn activators, key physicochemical parameters did not meet the requirements of potential drug candidates.. Targeting the membrane-located channel requires subtly balancing lipophilicity, activity, and aqueous solubility. Article Title: Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties Article Snippet: Using a set of six physicochemical parameters ((a) lipophilicity, calculated partition coefficient (ClogP); (b) calculated distribution coefficient at pH = 7.4 (ClogD); (c) molecular weight (MW); (d) topological polar surface area (TPSA); (e) number of hydrogen bond donors (HBD); (f) most basic center (p K a )), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs ( N = 119) and Article Title: Structural modifications that alter the P-glycoprotein efflux properties of compounds. Article Snippet: Retrospective analysis of marketed drugs has revealed that very low prevalence of P-glycoprotein (P-gp) efflux and moderate to high passive permeability are two key properties that distinguish drugs which engage targets in the central nervous system (CNS) from those that act predominantly in the periphery.. Quantification of the efflux properties that differentiate CNS drugs has been determined using in vitro assays for human and rodent P-gp, and revealed in vivo by comparing brain drug exposures in P-gp (mdr1a/b(−/−)) knockout mice against those observed in wild type mice.. Recognition by P-gp not only dramatically affects the distribution properties of compounds into bodily compartments including the CNS, testis, and placenta but also confers resistance to certain cancer chemotherapeutics. Article Title: Synthesis and Characterization of 9-(4-[ 18 F]Fluoro-3-(hydroxymethyl)butyl)-2-(phenylthio)-6-oxopurine as a Novel PET Agent for Mutant Herpes Simplex Virus Type 1 Thymidine Kinase Reporter Gene Imaging. Article Snippet: Purpose: [F]FHBG has been used as a positron emission tomography (PET) imaging tracer for the monitoring of herpes simplex virus type 1 thymidine kinase (HSV1-tk), a reporter gene for cell and gene therapy in humans.. However, this tracer shows inadequate blood-brain barrier (BBB) penetration and, therefore, would be limited for accurate quantification of reporter gene expression in the brain.. Here, we report the synthesis and evaluation of 9-(4-[F]fluoro-3(hydroxymethyl)butyl)-2(phenylthio)-6-oxopurine ([F]FHBT) as a new PET tracer for imaging reporter gene expression of HSV1-tk and its mutant HSV1-sr39tk, with the aim of improved BBB |